Literature DB >> 18286689

Infant intestinal Enterococcus faecalis down-regulates inflammatory responses in human intestinal cell lines.

Shugui Wang1, Lydia Hui Mei Ng, Wai Ling Chow, Yuan Kun Lee.   

Abstract

AIM: To investigate the ability of Lactic acid bacteria (LAB) to modulate inflammatory reaction in human intestinal cell lines (Caco-2, HT-29 and HCT116). Different strains of LAB isolated from new born infants and fermented milk, together with the strains obtained from culture collections were tested.
METHODS: LABs were treated with human intestinal cell lines. ELISA was used to detect IL-8 and TGF-beta protein secretion. Cytokines and Toll like receptors (TLRs) gene expression were assessed using RT-PCR. Conditional medium, sonicated bacteria and UV killed bacteria were used to find the effecter molecules on the bacteria. Carbohydrate oxidation and protein digestion were applied to figure out the molecules' residues. Adhesion assays were further carried out.
RESULTS: It was found that Enterococcus faecalis is the main immune modulator among the LABs by downregulation of IL-8 secretion and upregulation of TGF-beta. Strikingly, the effect was only observed in four strains of E. faecalis out of the 27 isolated and tested. This implies strain dependent immunomodulation in the host. In addition, E. faecalis may regulate inflammatory responses through TLR3, TLR4, TLR9 and TRAF6. Carbohydrates on the bacterial cell surface are involved in both its adhesion to intestinal cells and regulation of inflammatory responses in the host.
CONCLUSION: These data provide a case for the modulation of intestinal mucosal immunity in which specific strains of E. faecalis have uniquely evolved to maintain colonic homeostasis and regulate inflammatory responses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18286689      PMCID: PMC2689410          DOI: 10.3748/wjg.14.1067

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  30 in total

Review 1.  Probiotics: a role in the treatment of intestinal infection and inflammation?

Authors:  E Isolauri; P V Kirjavainen; S Salminen
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

2.  Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide.

Authors:  M T Abreu; P Vora; E Faure; L S Thomas; E T Arnold; M Arditi
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

3.  Allergy development and the intestinal microflora during the first year of life.

Authors:  B Björkstén; E Sepp; K Julge; T Voor; M Mikelsaar
Journal:  J Allergy Clin Immunol       Date:  2001-10       Impact factor: 10.793

Review 4.  Multiple control of interleukin-8 gene expression.

Authors:  Elke Hoffmann; Oliver Dittrich-Breiholz; Helmut Holtmann; Michael Kracht
Journal:  J Leukoc Biol       Date:  2002-11       Impact factor: 4.962

5.  Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression.

Authors:  F Nomura; S Akashi; Y Sakao; S Sato; T Kawai; M Matsumoto; K Nakanishi; M Kimoto; K Miyake; K Takeda; S Akira
Journal:  J Immunol       Date:  2000-04-01       Impact factor: 5.422

6.  Effect of probiotic strains on interleukin 8 production by HT29/19A cells.

Authors:  K M Lammers; U Helwig; E Swennen; F Rizzello; A Venturi; E Caramelli; M A Kamm; P Brigidi; P Gionchetti; M Campieri
Journal:  Am J Gastroenterol       Date:  2002-05       Impact factor: 10.864

Review 7.  Probiotics in clinical conditions.

Authors:  Philippe R Marteau
Journal:  Clin Rev Allergy Immunol       Date:  2002-06       Impact factor: 8.667

8.  Gnotobiotic IL-10-/-;NF-kappa B(EGFP) mice reveal the critical role of TLR/NF-kappa B signaling in commensal bacteria-induced colitis.

Authors:  Thomas Karrasch; Joo-Sung Kim; Marcus Muhlbauer; Scott T Magness; Christian Jobin
Journal:  J Immunol       Date:  2007-05-15       Impact factor: 5.422

9.  Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning?

Authors:  P V Kirjavainen; T Arvola; S J Salminen; E Isolauri
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

Review 10.  Toll-like receptors and their signaling mechanisms.

Authors:  Shizuo Akira; Shintaro Sato
Journal:  Scand J Infect Dis       Date:  2003
View more
  12 in total

1.  Adhesion and immunomodulatory effects of Bifidobacterium lactis HN019 on intestinal epithelial cells INT-407.

Authors:  Chang Liu; Zhuo-Yang Zhang; Ke Dong; Xiao-Kui Guo
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

2.  Enterococci and Their Interactions with the Intestinal Microbiome.

Authors:  Krista Dubin; Eric G Pamer
Journal:  Microbiol Spectr       Date:  2014-11

3.  Enterococcus faecalis Promotes Innate Immune Suppression and Polymicrobial Catheter-Associated Urinary Tract Infection.

Authors:  Brenda Yin Qi Tien; Hwee Mian Sharon Goh; Kelvin Kian Long Chong; Soumili Bhaduri-Tagore; Sarah Holec; Regine Dress; Florent Ginhoux; Molly A Ingersoll; Rohan B H Williams; Kimberly A Kline
Journal:  Infect Immun       Date:  2017-11-17       Impact factor: 3.441

Review 4.  Gram-Positive Uropathogens, Polymicrobial Urinary Tract Infection, and the Emerging Microbiota of the Urinary Tract.

Authors:  Kimberly A Kline; Amanda L Lewis
Journal:  Microbiol Spectr       Date:  2016-04

5.  The Effect of Lactobacillus acidophilus PTCC 1643 on Cultured Intestinal Epithelial Cells Infected with Salmonella enterica serovar Enteritidis.

Authors:  Mona Moshiri; Mohammad Mehdi Soltan Dallal; Farhad Rezaei; Masoumeh Douraghi; Laleh Sharifi; Zahra Noroozbabaei; Mehrdad Gholami; Abbas Mirshafiey
Journal:  Osong Public Health Res Perspect       Date:  2017-02-28

6.  Draft Genome Sequence of Enterococcus faecalis PC1.1, a Candidate Probiotic Strain Isolated from Human Feces.

Authors:  Páraic O Cuív; Eline S Klaassens; Wendy J Smith; Stanislas Mondot; A Scott Durkin; Derek M Harkins; Les Foster; Jamison McCorrison; Manolito Torralba; Karen E Nelson; Mark Morrison
Journal:  Genome Announc       Date:  2013-02-21

7.  Lactobacillus amylovorus inhibits the TLR4 inflammatory signaling triggered by enterotoxigenic Escherichia coli via modulation of the negative regulators and involvement of TLR2 in intestinal Caco-2 cells and pig explants.

Authors:  Alberto Finamore; Marianna Roselli; Ambra Imbinto; Julie Seeboth; Isabelle P Oswald; Elena Mengheri
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

8.  Enterococcus faecalis from healthy infants modulates inflammation through MAPK signaling pathways.

Authors:  Shugui Wang; Martin Lloyd Hibberd; Sven Pettersson; Yuan Kun Lee
Journal:  PLoS One       Date:  2014-05-15       Impact factor: 3.240

9.  Enterococcus faecalis AHG0090 is a Genetically Tractable Bacterium and Produces a Secreted Peptidic Bioactive that Suppresses Nuclear Factor Kappa B Activation in Human Gut Epithelial Cells.

Authors:  Páraic Ó Cuív; Rabina Giri; Emily C Hoedt; Michael A McGuckin; Jakob Begun; Mark Morrison
Journal:  Front Immunol       Date:  2018-04-18       Impact factor: 7.561

Review 10.  Parenteral Nutrition-Associated Liver Disease: The Role of the Gut Microbiota.

Authors:  Monika Cahova; Miriam Bratova; Petr Wohl
Journal:  Nutrients       Date:  2017-09-07       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.